| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |